273 related articles for article (PubMed ID: 34510322)
1. The emerging role of miR-200 family in metastasis: focus on EMT, CSCs, angiogenesis, and anoikis.
Babaei G; Raei N; Toofani Milani A; Gholizadeh-Ghaleh Aziz S; Pourjabbar N; Geravand F
Mol Biol Rep; 2021 Oct; 48(10):6935-6947. PubMed ID: 34510322
[TBL] [Abstract][Full Text] [Related]
2. Crosslink between p53 and metastasis: focus on epithelial-mesenchymal transition, cancer stem cell, angiogenesis, autophagy, and anoikis.
Babaei G; Aliarab A; Asghari Vostakolaei M; Hotelchi M; Neisari R; Gholizadeh-Ghaleh Aziz S; Bazl MR
Mol Biol Rep; 2021 Nov; 48(11):7545-7557. PubMed ID: 34519942
[TBL] [Abstract][Full Text] [Related]
3. MiR-204 down regulates SIRT1 and reverts SIRT1-induced epithelial-mesenchymal transition, anoikis resistance and invasion in gastric cancer cells.
Zhang L; Wang X; Chen P
BMC Cancer; 2013 Jun; 13():290. PubMed ID: 23768087
[TBL] [Abstract][Full Text] [Related]
4. Inhibitions of epithelial to mesenchymal transition and cancer stem cells-like properties are involved in miR-148a-mediated anti-metastasis of hepatocellular carcinoma.
Yan H; Dong X; Zhong X; Ye J; Zhou Y; Yang X; Shen J; Zhang J
Mol Carcinog; 2014 Dec; 53(12):960-9. PubMed ID: 23861222
[TBL] [Abstract][Full Text] [Related]
5. Epithelial-to-mesenchymal transition and cancer stem(-like) cells in head and neck squamous cell carcinoma.
Chen C; Zimmermann M; Tinhofer I; Kaufmann AM; Albers AE
Cancer Lett; 2013 Sep; 338(1):47-56. PubMed ID: 22771535
[TBL] [Abstract][Full Text] [Related]
6. DCLK1 regulates pluripotency and angiogenic factors via microRNA-dependent mechanisms in pancreatic cancer.
Sureban SM; May R; Qu D; Weygant N; Chandrakesan P; Ali N; Lightfoot SA; Pantazis P; Rao CV; Postier RG; Houchen CW
PLoS One; 2013; 8(9):e73940. PubMed ID: 24040120
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4.
Zhou JN; Zeng Q; Wang HY; Zhang B; Li ST; Nan X; Cao N; Fu CJ; Yan XL; Jia YL; Wang JX; Zhao AH; Li ZW; Li YH; Xie XY; Zhang XM; Dong Y; Xu YC; He LJ; Yue W; Pei XT
Hepatology; 2015 Sep; 62(3):801-15. PubMed ID: 25953743
[TBL] [Abstract][Full Text] [Related]
8. Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells.
Ren D; Wang M; Guo W; Huang S; Wang Z; Zhao X; Du H; Song L; Peng X
Cell Tissue Res; 2014 Dec; 358(3):763-78. PubMed ID: 25296715
[TBL] [Abstract][Full Text] [Related]
9. A family of pleiotropically acting microRNAs in cancer progression, miR-200: potential cancer therapeutic targets.
Zhang HF; Xu LY; Li EM
Curr Pharm Des; 2014; 20(11):1896-903. PubMed ID: 23888967
[TBL] [Abstract][Full Text] [Related]
10. MiR-525-5p Repressed Metastasis and Anoikis Resistance in Cervical Cancer via Blocking UBE2C/ZEB1/2 Signal Axis.
Chen M; Liu LX
Dig Dis Sci; 2020 Aug; 65(8):2442-2451. PubMed ID: 31679088
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-377 Counteracts With Cancer Stem Cell Phenotypes and Epithelial Mesenchymal Transformation by Targeting ZEB2 in Colon Cancer.
Shayimu P; Yusufu A; Rehemutula A; Redati D; Jiapaer R; Tuerdi R
Technol Cancer Res Treat; 2020; 19():1533033820967475. PubMed ID: 33084522
[TBL] [Abstract][Full Text] [Related]
12. An integrated analysis to predict micro-RNAs targeting both stemness and metastasis in human gastric cancer.
Azimi M; Totonchi M; Rahimi M; Firouzi J; Sahranavard P; Emami Razavi A; Memari F; Kamali F; Ebrahimi M
J Gastroenterol Hepatol; 2021 Feb; 36(2):436-445. PubMed ID: 32633423
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic silencing of microRNA-203 is required for EMT and cancer stem cell properties.
Taube JH; Malouf GG; Lu E; Sphyris N; Vijay V; Ramachandran PP; Ueno KR; Gaur S; Nicoloso MS; Rossi S; Herschkowitz JI; Rosen JM; Issa JP; Calin GA; Chang JT; Mani SA
Sci Rep; 2013; 3():2687. PubMed ID: 24045437
[TBL] [Abstract][Full Text] [Related]
14. Targeting microRNAs in epithelial-to-mesenchymal transition-induced cancer stem cells: therapeutic approaches in cancer.
Garg M
Expert Opin Ther Targets; 2015 Feb; 19(2):285-97. PubMed ID: 25563894
[TBL] [Abstract][Full Text] [Related]
15. Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells.
Nalls D; Tang SN; Rodova M; Srivastava RK; Shankar S
PLoS One; 2011; 6(8):e24099. PubMed ID: 21909380
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.
Xia H; Hui KM
Cancer Gene Ther; 2012 Nov; 19(11):723-30. PubMed ID: 22975591
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs in colorectal cancer metastasis.
de Krijger I; Mekenkamp LJ; Punt CJ; Nagtegaal ID
J Pathol; 2011 Aug; 224(4):438-47. PubMed ID: 21706478
[TBL] [Abstract][Full Text] [Related]
18. Regulating miRNA by natural agents as a new strategy for cancer treatment.
Sethi S; Li Y; Sarkar FH
Curr Drug Targets; 2013 Sep; 14(10):1167-74. PubMed ID: 23834152
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic cancer stem cells: emerging target for designing novel therapy.
Li Y; Kong D; Ahmad A; Bao B; Sarkar FH
Cancer Lett; 2013 Sep; 338(1):94-100. PubMed ID: 22445908
[TBL] [Abstract][Full Text] [Related]
20. A Bibenzyl from Dendrobium ellipsophyllum inhibits epithelial-to-mesenchymal transition and sensitizes lung cancer cells to anoikis.
Chaotham C; Pongrakhananon V; Sritularak B; Chanvorachote P
Anticancer Res; 2014 Apr; 34(4):1931-8. PubMed ID: 24692728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]